Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors

被引：4

作者：

Cheng, Hengmiao ^{[1
]}

Li, Puhui ^{[1
]}

Chen, Ping ^{[1
]}

Irimia, Adriana ^{[1
]}

Bae, Jae Hyun ^{[1
]}

Brooun, Alexei ^{[1
]}

Fagan, Patrick ^{[1
]}

Lam, Richard ^{[1
]}

Lin, Bingzhen ^{[1
]}

Zhang, Jingchuan ^{[1
]}

Zhan, Xuejun ^{[2
]}

Wu, Xu ^{[2
]}

Xie, Nan ^{[3
]}

Chiang, Gary ^{[1
]}

Shoemaker, Robert ^{[1
]}

Vernier, Jean-Michel ^{[1
]}

机构：

[1] Erasca Inc, San Diego, CA 92121 USA

[2] Wuxi AppTec Wuhan Co Ltd, Wuhan 430075, Hubei, Peoples R China

[3] Wuxi AppTec Shanghai Co Ltd, Shanghai 200131, Peoples R China

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2023年 / 14卷 / 10期

关键词：

KRAS; G12D selective inhibitor; ERAS-5024; SBDD; PDAC; anti-tumor efficacy;

D O I：

10.1021/acsmedchemlett.3c00245

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

KRAS G12D mutation has been found in approximately 45% of pancreatic ductal adeno-carcinoma (PDAC) cases, making it an attractive therapeutic target. Through structure-based drug design, a series of potent and selective KRAS G12D inhibitors were designed. The lead compound, ERAS-5024, inhibited ERK1/2 phosphorylation and cell proliferation in three-dimensional Cell-Titer Glo assays in AsPC-1 PDAC cells with single-digit nanomolar potency and caused tumor regression in the in vivo efficacy studies. We describe here the details of the design and synthesis program that led to the discovery of ERAS-5024.

引用

页码：1351 / 1357

页数：7

共 50 条

[41] Mutant-selective, covalent inhibitors of K-Ras(G12D)
Zheng, Qinheng
Zhang, Ziyang
Guiley, Keelan
Shokat, Kevan
CANCER RESEARCH, 2024, 84 (02)
[42] Selective epithelial activation of KRAS G12D mutation drives ductal pancreatic neoplasia in pigs
Jara, Carlos P.
Al-Gahmi, Al-Murtadha
Le, Binh
Carlson, Mark A.
CANCER RESEARCH, 2024, 84 (02)
[43] HBW-012-D and HBW-012-E are novel, potent, selective, safe, and bioavailable KRAS G12D inhibitors with superior anti-tumor efficacy in mice
Lee, Ning
Li, Yingfu
Liu, Guanfeng
Li, Jiang
Ren, Junfeng
CANCER RESEARCH, 2024, 84 (06)
[44] Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors
Futamura-Takahashi, Junko
Tanaka, Taisaku
Sugawara, Hajime
Iwashita, Shinzo
Imajo, Seiichi
Oyama, Yoshiaki
Muto, Tsuyoshi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (02) : 188 - 192
[45] Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
Kim, SH
Pudzianowski, AT
Leavitt, KJ
Barbosa, J
McDonnell, PA
Metzler, WJ
Rankin, BM
Liu, R
Vaccaro, W
Pitts, W
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 1101 - 1106
[46] Structure-based design of potent and selective inhibitors of NF-κB inducing kinase (NIK)
Blaquiere, Nicole
Staben, Steven
Castanedo, Georgette
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[47] Structure-based design of potent and selective DLG-out RIPK1 inhibitors
Suebsuwong, Chalada
Najjar, Malek
Ray, Soumya
Thapa, Roshan
Maki, Jenny
Nogusa, Shoko
Shah, Saumil
Saleh, Danish
Gough, Peter
Bertin, John
Yuan, Junying
Balachandran, Siddharth
Cuny, Gregory
Degterev, Alexei
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[48] Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
Hu, Dennis X.
Patel, Snahel
Chen, Huifen
Wang, Shumei
Staben, Steven T.
Dimitrova, Yoana N.
Wallweber, Heidi Ackerly
Lee, Joanna Y.
Chan, Grace Ka Yan
Sneeringer, Christopher J.
Prangley, Madeleine S.
Moffat, John G.
Wu, Kai C.
Schutt, Leah K.
Salphati, Laurent
Pang, Jodie
McNamara, Erin
Huang, Haochu
Chen, Yong
Wang, Yunli
Zhao, Wensheng
Lim, Junghyun
Murthy, Aditya
Siu, Michael
JOURNAL OF MEDICINAL CHEMISTRY, 2021, : 11500 - 11512
[49] The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase
Zuccotto, F
Brun, R
Pacanowska, DG
Perez, LMR
Gilbert, IH
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (10) : 1463 - 1468
[50] Structure-based design of novel potent nonpeptide thrombin inhibitors
Hauel, NH
Nar, H
Priepke, H
Ries, U
Stassen, JM
Wienen, W
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1757 - 1766

← 1 2 3 4 5 →